Can India break this Pharma Monopoly?
The Daily Brief
00:00
The Battle for Pharmaceutical Patents: Novo Nordisk vs. Indian Generics
This chapter explores the legal and competitive tensions between Novo Nordisk and Indian generic drug manufacturers over the patent of semaglutide. It highlights the implications of patent expiration, market entry by companies like Dr. Reddy's Laboratories, and the ethical questions surrounding drug patents and innovation.
Transcript
Play full episode
